Walking the pharma supply chain tightrope requires more than precision
Global pharma supply chains are susceptible to disruption due to geopolitical, natural disasters, and pandemics. IM Imagery via Shutterstock.com. Between
Read MoreGlobal pharma supply chains are susceptible to disruption due to geopolitical, natural disasters, and pandemics. IM Imagery via Shutterstock.com. Between
Read MoreHorseshoe crabs are living fossils, older than trees—they predate dinosaurs by 200 million years, survived the asteroid that ended the
Read MoreAfter a year filled with tariffs, partnership deals, and government reworks aiming to reduce the cost of healthcare and medications
Read MoreTrump, pharmaceutical companies strike deal to cut drug prices U.S. President Donald Trump and nine major pharmaceutical companies on Friday
Read MoreThe pharmaceutical leader continues to grab headlines. Investors looking to capitalize on the growing artificial intelligence (AI) industry are mostly
Read MorePfizer CEO Albert Bourla joined President Trump at the White House on Sept. 30 to announce a voluntary effort to
Read MoreTariff implementation in early 2025 has accelerated decision-making timelines for pharmaceutical companies reassessing their global manufacturing networks. On 13 January
Read MoreThe Delaware Department of Justice announced on Wednesday, January 14, 2026, that a lawsuit has been filed in the Court
Read More(The Center Square) – Drug products for oncology and neurological diseases will be manufactured in a second facility Johnson &
Read MoreGALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically integrated
Read More